Please provide your email address to receive an email when new articles are posted on . The mechanisms governing immune-related adverse events resulting from checkpoint inhibition therapy for cancer ...
Cancer Survivorship Practices Among Cancer Care Providers and Cancer Centers in Brazil: Results From a National Survey We conducted a retrospective cohort study of adults with solid tumors treated ...
Analyzing fatigue as a common adverse effect in patients treated with immune checkpoint inhibitors. This is an ASCO Meeting Abstract from the 2025 ASCO Annual Meeting I. This abstract does not include ...
Immunotherapy-related skin adverse events may correlate with improved tumor response and survival, underlining their clinical significance. Dermoscopy can noninvasively identify immune checkpoint ...
Patients stopping immunotherapy due to side effects still experienced long-term benefits, with survival extending beyond 7 years. Factors predicting longer survival after treatment discontinuation ...
Non-small cell lung cancer (NSCLC) accounts for the majority of lung cancer cases and remains a leading cause of cancer mortality worldwide. Epidermal growth factor receptor (EGFR) mutations are ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results